3419 related articles for article (PubMed ID: 15322536)
21. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
[TBL] [Abstract][Full Text] [Related]
22. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice.
Tang Q; Adams JY; Tooley AJ; Bi M; Fife BT; Serra P; Santamaria P; Locksley RM; Krummel MF; Bluestone JA
Nat Immunol; 2006 Jan; 7(1):83-92. PubMed ID: 16311599
[TBL] [Abstract][Full Text] [Related]
23. A function for interleukin 2 in Foxp3-expressing regulatory T cells.
Fontenot JD; Rasmussen JP; Gavin MA; Rudensky AY
Nat Immunol; 2005 Nov; 6(11):1142-51. PubMed ID: 16227984
[TBL] [Abstract][Full Text] [Related]
24. CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions.
Suvas S; Azkur AK; Kim BS; Kumaraguru U; Rouse BT
J Immunol; 2004 Apr; 172(7):4123-32. PubMed ID: 15034024
[TBL] [Abstract][Full Text] [Related]
25. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis.
Möttönen M; Heikkinen J; Mustonen L; Isomäki P; Luukkainen R; Lassila O
Clin Exp Immunol; 2005 May; 140(2):360-7. PubMed ID: 15807863
[TBL] [Abstract][Full Text] [Related]
26. In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death.
Fritzsching B; Oberle N; Eberhardt N; Quick S; Haas J; Wildemann B; Krammer PH; Suri-Payer E
J Immunol; 2005 Jul; 175(1):32-6. PubMed ID: 15972628
[TBL] [Abstract][Full Text] [Related]
27. Early detection of tumor cells by innate immune cells leads to T(reg) recruitment through CCL22 production by tumor cells.
Faget J; Biota C; Bachelot T; Gobert M; Treilleux I; Goutagny N; Durand I; Léon-Goddard S; Blay JY; Caux C; Ménétrier-Caux C
Cancer Res; 2011 Oct; 71(19):6143-52. PubMed ID: 21852386
[TBL] [Abstract][Full Text] [Related]
28. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells.
Vieira PL; Christensen JR; Minaee S; O'Neill EJ; Barrat FJ; Boonstra A; Barthlott T; Stockinger B; Wraith DC; O'Garra A
J Immunol; 2004 May; 172(10):5986-93. PubMed ID: 15128781
[TBL] [Abstract][Full Text] [Related]
29. Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells.
Forward NA; Furlong SJ; Yang Y; Lin TJ; Hoskin DW
J Leukoc Biol; 2010 Jan; 87(1):117-25. PubMed ID: 19843574
[TBL] [Abstract][Full Text] [Related]
30. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes.
Chen Z; Herman AE; Matos M; Mathis D; Benoist C
J Exp Med; 2005 Nov; 202(10):1387-97. PubMed ID: 16301745
[TBL] [Abstract][Full Text] [Related]
31. Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma.
Yang ZZ; Novak AJ; Stenson MJ; Witzig TE; Ansell SM
Blood; 2006 May; 107(9):3639-46. PubMed ID: 16403912
[TBL] [Abstract][Full Text] [Related]
32. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
[TBL] [Abstract][Full Text] [Related]
33. CCL22 Signaling in the Tumor Environment.
Röhrle N; Knott MML; Anz D
Adv Exp Med Biol; 2020; 1231():79-96. PubMed ID: 32060848
[TBL] [Abstract][Full Text] [Related]
34. Distinct and overlapping roles of interleukin-10 and CD25+ regulatory T cells in the inhibition of antitumor CD8 T-cell responses.
Dercamp C; Chemin K; Caux C; Trinchieri G; Vicari AP
Cancer Res; 2005 Sep; 65(18):8479-86. PubMed ID: 16166328
[TBL] [Abstract][Full Text] [Related]
35. Induction of CD4(+)CD25(+)Foxp3(-) regulatory T cells by Thy-1 stimulation of CD4(+) T cells.
Conrad DM; Coombs MR; Furlong SJ; Forward NA; Hoskin DW
Immunol Cell Biol; 2012 Feb; 90(2):248-52. PubMed ID: 21519344
[TBL] [Abstract][Full Text] [Related]
36. Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo.
Tadokoro CE; Shakhar G; Shen S; Ding Y; Lino AC; Maraver A; Lafaille JJ; Dustin ML
J Exp Med; 2006 Mar; 203(3):505-11. PubMed ID: 16533880
[TBL] [Abstract][Full Text] [Related]
37. CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis.
Kumar M; Putzki N; Limmroth V; Remus R; Lindemann M; Knop D; Mueller N; Hardt C; Kreuzfelder E; Grosse-Wilde H
J Neuroimmunol; 2006 Nov; 180(1-2):178-84. PubMed ID: 17011048
[TBL] [Abstract][Full Text] [Related]
38. Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta.
Liu VC; Wong LY; Jang T; Shah AH; Park I; Yang X; Zhang Q; Lonning S; Teicher BA; Lee C
J Immunol; 2007 Mar; 178(5):2883-92. PubMed ID: 17312132
[TBL] [Abstract][Full Text] [Related]
39. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction.
Castellino F; Huang AY; Altan-Bonnet G; Stoll S; Scheinecker C; Germain RN
Nature; 2006 Apr; 440(7086):890-5. PubMed ID: 16612374
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma.
Wei S; Kryczek I; Edwards RP; Zou L; Szeliga W; Banerjee M; Cost M; Cheng P; Chang A; Redman B; Herberman RB; Zou W
Cancer Res; 2007 Aug; 67(15):7487-94. PubMed ID: 17671219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
